Table: Kyorin Holdings -2016/17 group results

Kyorin Pharmaceutical

11/05/2017 06:30

May 11 (Reuters)-  
          Kyorin Holdings Inc  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to       NEXT    
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales          115.37          119.48         113.40        54.60     
               (-3.4 pct)      (+5.6 pct)     (-1.7 pct)    (-0.1 pct)  
  Operating       10.41           19.64          12.10         5.30     
               (-47.0 pct)     (+33.2 pct)    (+16.2 pct)  (+44.7 pct)  
  Recurring       10.87           20.00          12.60         5.60     
               (-45.6 pct)     (+29.1 pct)    (+15.9 pct)  (+42.8 pct)  
  Net 
  Net              7.31           13.64           9.70         4.50     
               (-46.4 pct)     (+13.1 pct)    (+32.8 pct)  (+67.6 pct)  
  EPS           99.45 yen      184.28 yen     131.94 yen    61.21 yen   
  Ann Div       58.00 yen       58.00 yen      58.00 yen                
  -Q2 Div       20.00 yen       20.00 yen      20.00 yen                
  -Q4 Div       38.00 yen       38.00 yen      38.00 yen                
   
  NOTE - Kyorin Holdings Inc. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T 
  ((Tokyo Headline News Desk +813 6441 1812))